Cancer is the leading cause of morbidity and mortality in people throughout the world. There are many signaling pathways associated with cancerous diseases, from which the Mitogen-activated protein kinase (MAPK) pathway performs a significant role in this regard. Apoptosis and proliferation are correlated with MAPK signaling pathways. Plenty of experimental investigations were carried out to assess the role of indole alkaloids in MAPK-mediated cancerous diseases. Previous reports established that indole alkaloids, such as vincristine and evodiamine are useful small molecules in cancer treatment via the MAPK signaling system. Indole alkaloids have the anticancer potential through different pathways. Vincristine and evodiamine are naturally occurring indole alkaloids that have strong anticancer properties. Additionally, much research is ongoing or completed with molecules belonging to this group. The current review aims to evaluate how indole alkaloids affect the MAPK signaling pathway in cancer treatment. Additionally, we focused on the advancement in the role of indole alkaloids, with the intention of modifying the MAPK signaling pathways to investigate potential new anticancer small molecules. Furthermore, clinical trials with indole alkaloids in cancer treatment are also highlighted.
Compared to pharmaceutical drugs, herbal medications have known to be more affordable and better for the treatment of many diseases but are less effective and not targeted. Therefore, the use of innovative drug delivery devices to distribute herbal drugs is very helpful in enhancing their release, potency and operation. Lycopene was introduced into the muco-adhesive microspheres. Using sodium alginate, carbopol 934, and sodium CMCC, mucoadhesive microspheres were prepared (carboxy methyl cellulose). The prepared microspheres had been evaluated for its physical and physicochemical parameters, invitro release. The prepared microspheres showed consistent physicochemical parameters, release sustained to 8hrs. Herbal drugs can preferably be delivered using novel drug delivery systems after proper chemical and biological standardization.